Speak with a Health Economics Expert

Across recent ISPOR surveys, >60 % of respondents cited access, ownership, and transparency barriers as their biggest challenges to efficient and timely economic modeling.

We combine world-class health economics expertise with purpose-built software to help you quantify the value or a new treatment and identify the needed evidence to support and communicate that value. Tell us what you’re working on — we’ll follow up within one business day.

Featured EntityRisk Recent Wins:

  • Base-case value based price +84% vs ICER
  • 18/20 drugs shown to be cost-effective under GCEA vs 8/20 under ICER
  • GCEA price >20% higher than traditional CEA
  • Model and analyses delivered 70% faster than traditional consulting
  • ICER: $11K vs EntityRisk: $61K

Leverage software built by a team with world- class scientific, engineering and industry credentials.